A Scalable Route to the SMO Receptor Antagonist SEN826: Benzimidazole Synthesis via Enhanced in Situ Formation of the Bisulfite–Aldehyde Complex

MLA

Paul H. Wiedenau, et al. “A Scalable Route to the SMO Receptor Antagonist SEN826: Benzimidazole Synthesis via Enhanced in Situ Formation of the Bisulfite–Aldehyde Complex.” Organic Process Research & Development, vol. 18, June 2014, pp. 699–708. EBSCOhost, https://doi.org/10.1021/op4002092.

APA

Paul H. Wiedenau, Matteo Betti, Salvatore Sanna Coccone, Eva Genesio, & Guido Marconi. (2014). A Scalable Route to the SMO Receptor Antagonist SEN826: Benzimidazole Synthesis via Enhanced in Situ Formation of the Bisulfite–Aldehyde Complex. Organic Process Research & Development, 18, 699–708. https://doi.org/10.1021/op4002092

Chicago

Paul H. Wiedenau, Matteo Betti, Salvatore Sanna Coccone, Eva Genesio, and Guido Marconi. 2014. “A Scalable Route to the SMO Receptor Antagonist SEN826: Benzimidazole Synthesis via Enhanced in Situ Formation of the Bisulfite–Aldehyde Complex.” Organic Process Research & Development 18 (June): 699–708. doi:10.1021/op4002092.